Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q2 2023 Earnings

7AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.45

-0.4

-0.35

-0.3

Details

Expected EPS

-0.45

Actual EPS

-0.42

Surprise EPS

0.03

Surprise Percent

+6.67%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.42 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.